(Q33374714)

26 July 2017

title

A randomised study comparing standard dose carboplatin with chlorambucil and carboplatin in advanced ovarian cancer (English)

1 reference

https://api.crossref.org/works/10.1038/BJC.1992.55

26 July 2017

1 reference

1 reference

1 reference

1 reference

13 November 2022

author name string

E. M. Rankin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739629

13 November 2022

L. Mill

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739629

13 November 2022

S. B. Kaye

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739629

13 November 2022

R. Atkinson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739629

13 November 2022

L. Cassidy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739629

13 November 2022

J. Cordiner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739629

13 November 2022

D. Cruickshank

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739629

13 November 2022

J. Davis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739629

13 November 2022

I. D. Duncan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739629

13 November 2022

W. Fullerton

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739629

13 November 2022

language of work or name

English

0 references

publication date

1 February 1992

1 reference

full work available at URL

26 July 2017

https://europepmc.org/articles/PMC1977737

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739629

https://europepmc.org/articles/PMC1977737?pdf=render

13 November 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739629

http://www.nature.com/articles/bjc199255.pdf

13 November 2022

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/BJC.1992.55

http://www.nature.com/articles/bjc199255

13 November 2022

1 reference

https://api.crossref.org/works/10.1038/BJC.1992.55

British Journal of Cancer

13 November 2022

published in

1 reference

26 July 2017

volume

65

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

275-281

1 reference

Phase II study of JM8, a new platinum analog, in advanced ovarian carcinoma

26 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977737

Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977737

Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977737

Average relative dose intensity and the impact on design of clinical trials.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977737

Controversy over combination chemotherapy in advanced ovarian cancer: what we learn from reports of matured data

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977737

A pilot study of carboplatin (JM8, CBDCA) and chlorambucil in combination for advanced ovarian cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977737

High-dose cisplatin in hypertonic saline in refractory ovarian cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977737

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977737

Cyclophosphamide-cisplatin versus cyclophosphamide-carboplatin in stage III-IV ovarian carcinoma: a comparison of equally myelosuppressive regimens

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977737

Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977737

A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposide

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977737

The case for combination chemotherapy in the treatment of advanced ovarian cancer

14 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1739629

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Chemotherapy of ovarian cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1739629

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.1992.55

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference

26 July 2017

1 reference